Stereotaxis (STXS)
Builds magnetic-navigation robots and catheters for cardiac electrophysiology.
$1.40
After hours+0.01 (+1.08%)
At close$1.39(+1.84%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 7 | 5 | 9 | 6 | 7 | 9 | 7 | 9 | 6 | 8 |
| Cost of revenue | 2 | 3 | 1 | 5 | 3 | 3 | 4 | 3 | 4 | 2 | 3 |
| Gross profit | 3 | 4 | 3 | 4 | 3 | 4 | 5 | 4 | 4 | 4 | 4 |
| 8 | 9 | 9 | 10 | 11 | 10 | 9 | 11 | 10 | 9 | 9 | |
| Research & development | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 2 | 2 |
| 6 | 6 | 7 | 8 | 8 | 8 | 7 | 8 | 7 | 7 | 7 | |
| Selling & marketing | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| General & administrative | 3 | 3 | 4 | 5 | 5 | 4 | 4 | 5 | 4 | 5 | 4 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 |
| Operating income | −5 | −5 | −6 | −6 | −8 | −6 | −4 | −7 | −6 | −5 | −5 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Income before tax | −5 | −5 | −6 | −6 | −8 | −6 | −4 | −6 | −6 | −6 | −4 |
| Net income from continuing operations | −5 | −5 | −6 | −6 | −8 | −6 | −4 | −6 | −6 | −6 | −4 |
| Net income | −5 | −5 | −6 | −6 | −8 | −6 | −4 | −6 | −6 | −6 | −4 |
| EPS, basic | −$0.07 | −$0.06 | −$0.07 | −$0.08 | −$0.09 | −$0.07 | −$0.05 | −$0.07 | −$0.06 | −$0.06 | −$0.05 |
| EPS, diluted | −$0.07 | −$0.06 | −$0.07 | −$0.08 | −$0.09 | −$0.07 | −$0.05 | −$0.07 | −$0.06 | −$0.06 | −$0.05 |
| Weighted average shares, basic | 83 | 83 | 85 | 86 | 87 | 88 | 88 | 92 | 96 | 99 | 100 |
| Weighted average shares, diluted | 83 | 83 | 85 | 86 | 87 | 88 | 88 | 92 | 96 | 99 | 100 |
| EBITDA | −5 | −4 | −6 | −6 | −7 | −5 | −3 | −6 | −5 | −5 | −4 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −5 | −5 | −6 | −6 | −8 | −6 | −4 | −6 | −6 | −6 | −4 |